相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The emerging plasticity of SARS-CoV-2
Kevin D. McCormick et al.
SCIENCE (2021)
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng et al.
CELL REPORTS (2021)
Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
Darren M. Griffith et al.
CHEMICAL SOCIETY REVIEWS (2021)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Bismuth Porphyrin Antagonizes Cisplatin-Induced Nephrotoxicity via Unexpected Metallothionein-Independent Mechanisms
Runming Wang et al.
ISCIENCE (2020)
Discovery of Antibacterials That Inhibit Bacterial RNA Polymerase Interactions with Sigma Factors
Jiqing Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
Michael K. Lo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
Hongzhe Sun et al.
NATURE COMMUNICATIONS (2020)
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly et al.
LANCET RESPIRATORY MEDICINE (2020)
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
Shuofeng Yuan et al.
NATURE MICROBIOLOGY (2020)
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Zhongcheng Shi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
Hongyan Li et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
FDA recalls ranitidine medicines over potential cancer causing impurity
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2019)
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
Jian Lei et al.
ANTIVIRAL RESEARCH (2018)
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Runming Wang et al.
NATURE COMMUNICATIONS (2018)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
Yifan Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Recent advances in bioinorganic chemistry of bismuth
Hongyan Li et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2012)
Everted gut sac model as a tool in pharmaceutical research: limitations and applications
Mohd Aftab Alam et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
Janina Geiler et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
Shujian Cun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A histidine-rich and cysteine-rich metal-binding domain at the C terminus of heat shock protein A from Helicobacter pylori -: Implication for nickel homeostasis and bismuth susceptibility
Shujian Cun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
Alexander C. Ford et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Bismuth complexes inhibit the SARS coronavirus
Nan Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Antioxidant properties of N-acetylcysteine:: their relevance in relation to chronic obstructive pulmonary disease
PNR Dekhuijzen
EUROPEAN RESPIRATORY JOURNAL (2004)
Identification, isolation, and characterization of cysteinate and thiolactate complexes of bismuth
GG Briand et al.
INORGANIC CHEMISTRY (2004)
Structure of colloidal bismuth subcitrate (CBS) in dilute HCl:: Unique assembly of bismuth citrate dinuclear units ([Bi(cit)2Bi]2-)
W Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Bismuth subcitrate nephrotoxicity - A reversible cause of acute oliguric renal failure
M Sarikaya et al.
NEPHRON (2002)
Bismuth biokinetics and kidney histopathology after bismuth overdose in rats
BT Leussink et al.
ARCHIVES OF TOXICOLOGY (2000)
分享论文
